Cargando…

Use of a novel shockwave trode results in better patient acceptance in awake canine patients treated for musculoskeletal disease

INTRODUCTION: Extracorporeal shockwave therapy (ESWT) is used as a treatment option for several musculoskeletal pathologies in dogs. When performing ESWT using electrohydraulic devices, sedation is commonly recommended due to the noise and discomfort associated with the treatment. The aim of this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Joseph, Gina L., Duerr, Felix M., Zhou, Tianjian, Elam, Lindsay H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445390/
https://www.ncbi.nlm.nih.gov/pubmed/37621864
http://dx.doi.org/10.3389/fvets.2023.1249592
_version_ 1785094163637731328
author Joseph, Gina L.
Duerr, Felix M.
Zhou, Tianjian
Elam, Lindsay H.
author_facet Joseph, Gina L.
Duerr, Felix M.
Zhou, Tianjian
Elam, Lindsay H.
author_sort Joseph, Gina L.
collection PubMed
description INTRODUCTION: Extracorporeal shockwave therapy (ESWT) is used as a treatment option for several musculoskeletal pathologies in dogs. When performing ESWT using electrohydraulic devices, sedation is commonly recommended due to the noise and discomfort associated with the treatment. The aim of this study was to compare the tolerance of ESWT delivered by a standard or novel trode in awake canine patients with musculoskeletal disease. MATERIALS AND METHODS: This was a prospective, blinded clinical trial in which dogs with musculoskeletal disease received awake treatment with ESWT with a gradually increasing energy protocol using both standard and novel trodes with an electrohydraulic generator in a randomized fashion. Noise reactivity and tolerance to treatment as measured in number of shocks and energy level achieved were recorded. RESULTS: Forty client-owned dogs with pathology affecting the hips, stifles, elbows, or shoulders were enrolled. Thirty-three dogs completed all three treatment sessions, three dogs completed two sessions, and four dogs completed one session. There was evidence of improved patient tolerability with the novel trode, based on an increased average number of shocks delivered (n ± SD = 848 ± 334 for novel trode; n ± SD = 767 ± 358 for standard trode; p = 0.0384) and higher average treatment energy level achieved (E ± SD = 6.5 ± 2.5 for novel trode; E ± SD = 5.3 ± 2.8 for standard trode; p = < 0.001). Decreased noise reactivity was found to be positively correlated with tolerability of shockwave treatment (energy level: p = 0.0168; number of shocks: p = 0.0097). DISCUSSION: Administration of electrohydraulic ESWT is feasible in select awake patients using a gradually increasing energy protocol, and the tested novel shockwave trode is better tolerated than the standard trode. Further studies are required to determine the efficacy of the novel trode, and if gradually increasing energy protocols are clinically equivalent to current standard protocols that employ a consistent energy level.
format Online
Article
Text
id pubmed-10445390
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104453902023-08-24 Use of a novel shockwave trode results in better patient acceptance in awake canine patients treated for musculoskeletal disease Joseph, Gina L. Duerr, Felix M. Zhou, Tianjian Elam, Lindsay H. Front Vet Sci Veterinary Science INTRODUCTION: Extracorporeal shockwave therapy (ESWT) is used as a treatment option for several musculoskeletal pathologies in dogs. When performing ESWT using electrohydraulic devices, sedation is commonly recommended due to the noise and discomfort associated with the treatment. The aim of this study was to compare the tolerance of ESWT delivered by a standard or novel trode in awake canine patients with musculoskeletal disease. MATERIALS AND METHODS: This was a prospective, blinded clinical trial in which dogs with musculoskeletal disease received awake treatment with ESWT with a gradually increasing energy protocol using both standard and novel trodes with an electrohydraulic generator in a randomized fashion. Noise reactivity and tolerance to treatment as measured in number of shocks and energy level achieved were recorded. RESULTS: Forty client-owned dogs with pathology affecting the hips, stifles, elbows, or shoulders were enrolled. Thirty-three dogs completed all three treatment sessions, three dogs completed two sessions, and four dogs completed one session. There was evidence of improved patient tolerability with the novel trode, based on an increased average number of shocks delivered (n ± SD = 848 ± 334 for novel trode; n ± SD = 767 ± 358 for standard trode; p = 0.0384) and higher average treatment energy level achieved (E ± SD = 6.5 ± 2.5 for novel trode; E ± SD = 5.3 ± 2.8 for standard trode; p = < 0.001). Decreased noise reactivity was found to be positively correlated with tolerability of shockwave treatment (energy level: p = 0.0168; number of shocks: p = 0.0097). DISCUSSION: Administration of electrohydraulic ESWT is feasible in select awake patients using a gradually increasing energy protocol, and the tested novel shockwave trode is better tolerated than the standard trode. Further studies are required to determine the efficacy of the novel trode, and if gradually increasing energy protocols are clinically equivalent to current standard protocols that employ a consistent energy level. Frontiers Media S.A. 2023-08-09 /pmc/articles/PMC10445390/ /pubmed/37621864 http://dx.doi.org/10.3389/fvets.2023.1249592 Text en Copyright © 2023 Joseph, Duerr, Zhou and Elam. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Veterinary Science
Joseph, Gina L.
Duerr, Felix M.
Zhou, Tianjian
Elam, Lindsay H.
Use of a novel shockwave trode results in better patient acceptance in awake canine patients treated for musculoskeletal disease
title Use of a novel shockwave trode results in better patient acceptance in awake canine patients treated for musculoskeletal disease
title_full Use of a novel shockwave trode results in better patient acceptance in awake canine patients treated for musculoskeletal disease
title_fullStr Use of a novel shockwave trode results in better patient acceptance in awake canine patients treated for musculoskeletal disease
title_full_unstemmed Use of a novel shockwave trode results in better patient acceptance in awake canine patients treated for musculoskeletal disease
title_short Use of a novel shockwave trode results in better patient acceptance in awake canine patients treated for musculoskeletal disease
title_sort use of a novel shockwave trode results in better patient acceptance in awake canine patients treated for musculoskeletal disease
topic Veterinary Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445390/
https://www.ncbi.nlm.nih.gov/pubmed/37621864
http://dx.doi.org/10.3389/fvets.2023.1249592
work_keys_str_mv AT josephginal useofanovelshockwavetroderesultsinbetterpatientacceptanceinawakecaninepatientstreatedformusculoskeletaldisease
AT duerrfelixm useofanovelshockwavetroderesultsinbetterpatientacceptanceinawakecaninepatientstreatedformusculoskeletaldisease
AT zhoutianjian useofanovelshockwavetroderesultsinbetterpatientacceptanceinawakecaninepatientstreatedformusculoskeletaldisease
AT elamlindsayh useofanovelshockwavetroderesultsinbetterpatientacceptanceinawakecaninepatientstreatedformusculoskeletaldisease